Whole-body diffusion-weighted MR and FDG-PET/CT in Hodgkin Lymphoma: Predictive role before treatment and early assessment after two courses of ABVD

MRI and PET in monitoring response in lymphoma

Alain Rahmouni
Alain Luciani
Emmanuel Itti

January 2005

The potential of FDG-PET and MRI in monitoring response to treatment in lymphoma is reviewed. Both F...

Automatic Prediction and Assessment of Treatment Response in Patients with Hodgkin’s Lymphoma Using a Whole-Body DW-MRI Based Approach

Brancato V.
Aiello M.
Della Pepa R.
Basso L.
Garbino N.
Nicolai E.
Picardi M.
Salvatore M.
Cavaliere C.

January 2020

The lack of validation and standardization represents the main drawback for a clear role of whole-bo...

FDG-PET Imaging for Hodgkin and Diffuse Large B-Cell Lymphoma—An Updated Overview

Voltin, Conrad-Amadeus
Mettler, Jasmin
Grosse, Jirka
Dietlein, Markus
Baues, Christian
Schmitz, Christine
Borchmann, Peter
Kobe, Carsten
Hellwig, Dirk

January 2020

Since the mid-1990s, F-18-fluorodeoxglucose (FDG)-positron emission tomography (PET) in combination ...

Whole-body diffusion-weighted MR and FDG-PET/CT in Hodgkin Lymphoma: Predictive role before treatment and early assessment after two courses of ABVD

Albano, Domenico
Patti, Caterina
Matranga, Domenica
Lagalla, Roberto
Midiri, Massimo
Galia, Massimo

January 2018

To evaluate whether imaging features of pathologic lymph nodes on whole-body diffusion-weighted MR h...

Whole-body diffusion weighted MR and FDG-PET/CT in Hodgkin lymphoma: predictive role before treatment and early assessment aftrer two courses of chemotheraphy

albano, d
patti, c
LA GRUTTA, Ludovico
MATRANGA, Domenica
grassedonio, e
ortolano, c
MIDIRI, Massimo
LAGALLA, Roberto
GALIA, Massimo

January 2017

To evaluate whether whole-body MR has a predictive role before treatment and may asses the response ...

Comparison of whole-body diffusion-weighted magnetic resonance and FDG-PET/CT in the assessment of Hodgkin's lymphoma for staging and treatment response

Montoro, Juan
Laszlo, Daniele
Zing, Natalia Pin Chuen
Petralia, Giuseppe
Conte, Giorgio
Colandrea, Marzia
Martinelli, Giovanni
PREDA, LORENZO

January 2014

Computed tomography (CT), 18F-fluorodeoxyglucose positron emission tomography (FDG-PET), and hybrid ...

Whole-body diffusion-weighted MRI in malignant lymphoma: staging and early treatment response assessment

De Paepe, Katja

January 2018

Malignant lymphoma is the 5th most common tumor type, comprising a large group of cancers with disti...

PET-MRI: NEW IMAGING TRENDS IN LYMPHOMA

Dr Rizwan
Syed Frcr
Lead Consultant Pet-mr
Rizwan Syed
Saima Riaz

January 2015

Positron emission tomography with 2-deoxy-2-fluoro-D-glucose integrated with computed tomography (FD...

Comparison between whole-body MRI with diffusion-weighted imaging and PET/CT in staging newly diagnosed FDG-avid lymphomas

Albano, D.
Patti, C.
La Grutta, L.
Agnello, F.
Grassedonio, E.
Mul\ue8, A.
Cannizzaro, G.
Ficola, U.
Lagalla, R.
Midiri, M.
Galia, M.

January 2016

Objectives To compare whole body-MRI (WB-MRI) with diffusion-weighted imaging and FDG-PET/CT in stag...

MAGNETIC RESONANCE IMAGING IN THE STAGING OF MALIGNANT LYMPHOMAS

A. I. Mikhaylov
I. E. Tyurin
V. O. Panov

February 2016

Computed tomography, 18FDG-PET and the hybrid FDGPET/CT are the most commonly used diagnostic tools ...

Whole-body diffusion-weighted magnetic resonance imaging by estimating the measurable diffusion coefficient in Hodgkin lymphoma

A. I. Mikhaylov
V. O. Panov
I. E. Tyurin

February 2016

Objective: to determine whether the measurable diffusion coefficient (MIC) may be used to differenti...

Whole-body MRI with diffusion-weighted imaging : A valuable alternative to contrast-enhanced CT for initial staging of aggressive lymphoma.

A. Balbo-Mussetto
S. Cirillo
R. Bruna
A. Gueli
C. Saviolo
M. Petracchini
A. Fornari
C. Lario
D. Gottardi
A. De Crescenzo
C. Tarella

March 2016

AIM: To compare the accuracy of whole-body magnetic resonance imaging (Wb-MRI) with diffusion-weig...

Role of Imaging in Lymphoma

Adams, H.J.A.

December 2015

The lymphomas comprise approximately 5.0% of all malignancies and are the sixth most frequently occu...

Whole-Body MRI and 18F-FDG-PET-CT for Lymphoma Staging: Comparison of Patient Experience

Agnello, F.
Albano, D.
LA GRUTTA, L.
Midiri, F.
Grassedonio, E.
Albano, G.
Mul\ue8, A.
Midiri, M.
Galia, M.

January 2015

To prospectively compare patient experience with whole-body MRI and 18F-FDG-PETCT in the initial sta...

Whole-body diffusie-gewogen MRI in het maligne lymfoom: stadiëring en vroege therapieopvolging

De Paepe, Katja

January 2018

Malignant lymphoma is the 5th most common tumor type, comprising a large group of cancers with disti...

MRI and PET in monitoring response in lymphoma

Alain Rahmouni
Alain Luciani
Emmanuel Itti

January 2005

The potential of FDG-PET and MRI in monitoring response to treatment in lymphoma is reviewed. Both F...

Automatic Prediction and Assessment of Treatment Response in Patients with Hodgkin’s Lymphoma Using a Whole-Body DW-MRI Based Approach

Brancato V.
Aiello M.
Della Pepa R.
Basso L.
Garbino N.
Nicolai E.
Picardi M.
Salvatore M.
Cavaliere C.

January 2020

The lack of validation and standardization represents the main drawback for a clear role of whole-bo...

FDG-PET Imaging for Hodgkin and Diffuse Large B-Cell Lymphoma—An Updated Overview

Voltin, Conrad-Amadeus
Mettler, Jasmin
Grosse, Jirka
Dietlein, Markus
Baues, Christian
Schmitz, Christine
Borchmann, Peter
Kobe, Carsten
Hellwig, Dirk

January 2020

Since the mid-1990s, F-18-fluorodeoxglucose (FDG)-positron emission tomography (PET) in combination ...

Whole-body diffusion-weighted MR and FDG-PET/CT in Hodgkin Lymphoma: Predictive role before treatment and early assessment after two courses of ABVD

Albano, Domenico
Patti, Caterina
Matranga, Domenica
Lagalla, Roberto
Midiri, Massimo
Galia, Massimo

January 2018

To evaluate whether imaging features of pathologic lymph nodes on whole-body diffusion-weighted MR h...

Whole-body diffusion weighted MR and FDG-PET/CT in Hodgkin lymphoma: predictive role before treatment and early assessment aftrer two courses of chemotheraphy

albano, d
patti, c
LA GRUTTA, Ludovico
MATRANGA, Domenica
grassedonio, e
ortolano, c
MIDIRI, Massimo
LAGALLA, Roberto
GALIA, Massimo

January 2017

To evaluate whether whole-body MR has a predictive role before treatment and may asses the response ...

Comparison of whole-body diffusion-weighted magnetic resonance and FDG-PET/CT in the assessment of Hodgkin's lymphoma for staging and treatment response

Montoro, Juan
Laszlo, Daniele
Zing, Natalia Pin Chuen
Petralia, Giuseppe
Conte, Giorgio
Colandrea, Marzia
Martinelli, Giovanni
PREDA, LORENZO

January 2014

Computed tomography (CT), 18F-fluorodeoxyglucose positron emission tomography (FDG-PET), and hybrid ...

Whole-body diffusion-weighted MRI in malignant lymphoma: staging and early treatment response assessment

De Paepe, Katja

January 2018

Malignant lymphoma is the 5th most common tumor type, comprising a large group of cancers with disti...

PET-MRI: NEW IMAGING TRENDS IN LYMPHOMA

Dr Rizwan
Syed Frcr
Lead Consultant Pet-mr
Rizwan Syed
Saima Riaz

January 2015

Positron emission tomography with 2-deoxy-2-fluoro-D-glucose integrated with computed tomography (FD...

Comparison between whole-body MRI with diffusion-weighted imaging and PET/CT in staging newly diagnosed FDG-avid lymphomas

Albano, D.
Patti, C.
La Grutta, L.
Agnello, F.
Grassedonio, E.
Mul\ue8, A.
Cannizzaro, G.
Ficola, U.
Lagalla, R.
Midiri, M.
Galia, M.

January 2016

Objectives To compare whole body-MRI (WB-MRI) with diffusion-weighted imaging and FDG-PET/CT in stag...

MAGNETIC RESONANCE IMAGING IN THE STAGING OF MALIGNANT LYMPHOMAS

A. I. Mikhaylov
I. E. Tyurin
V. O. Panov

February 2016

Computed tomography, 18FDG-PET and the hybrid FDGPET/CT are the most commonly used diagnostic tools ...

Whole-body diffusion-weighted magnetic resonance imaging by estimating the measurable diffusion coefficient in Hodgkin lymphoma

A. I. Mikhaylov
V. O. Panov
I. E. Tyurin

February 2016

Objective: to determine whether the measurable diffusion coefficient (MIC) may be used to differenti...

Whole-body MRI with diffusion-weighted imaging : A valuable alternative to contrast-enhanced CT for initial staging of aggressive lymphoma.

A. Balbo-Mussetto
S. Cirillo
R. Bruna
A. Gueli
C. Saviolo
M. Petracchini
A. Fornari
C. Lario
D. Gottardi
A. De Crescenzo
C. Tarella

March 2016

AIM: To compare the accuracy of whole-body magnetic resonance imaging (Wb-MRI) with diffusion-weig...

Role of Imaging in Lymphoma

Adams, H.J.A.

December 2015

The lymphomas comprise approximately 5.0% of all malignancies and are the sixth most frequently occu...

Whole-Body MRI and 18F-FDG-PET-CT for Lymphoma Staging: Comparison of Patient Experience

Agnello, F.
Albano, D.
LA GRUTTA, L.
Midiri, F.
Grassedonio, E.
Albano, G.
Mul\ue8, A.
Midiri, M.
Galia, M.

January 2015

To prospectively compare patient experience with whole-body MRI and 18F-FDG-PETCT in the initial sta...

Whole-body diffusie-gewogen MRI in het maligne lymfoom: stadiëring en vroege therapieopvolging

De Paepe, Katja

January 2018

Malignant lymphoma is the 5th most common tumor type, comprising a large group of cancers with disti...

MRI and PET in monitoring response in lymphoma

Alain Rahmouni
Alain Luciani
Emmanuel Itti

January 2005

The potential of FDG-PET and MRI in monitoring response to treatment in lymphoma is reviewed. Both F...

Automatic Prediction and Assessment of Treatment Response in Patients with Hodgkin’s Lymphoma Using a Whole-Body DW-MRI Based Approach

Brancato V.
Aiello M.
Della Pepa R.
Basso L.
Garbino N.
Nicolai E.
Picardi M.
Salvatore M.
Cavaliere C.

January 2020

The lack of validation and standardization represents the main drawback for a clear role of whole-bo...

FDG-PET Imaging for Hodgkin and Diffuse Large B-Cell Lymphoma—An Updated Overview

Voltin, Conrad-Amadeus
Mettler, Jasmin
Grosse, Jirka
Dietlein, Markus
Baues, Christian
Schmitz, Christine
Borchmann, Peter
Kobe, Carsten
Hellwig, Dirk

January 2020

Since the mid-1990s, F-18-fluorodeoxglucose (FDG)-positron emission tomography (PET) in combination ...

Whole-body diffusion-weighted MR and FDG-PET/CT in Hodgkin Lymphoma: Predictive role before treatment and early assessment after two courses of ABVD

Abstract

Extracted data

Whole-body diffusion-weighted MR and FDG-PET/CT in Hodgkin Lymphoma: Predictive role before treatment and early assessment after two courses of ABVD

Abstract

Extracted data

Related items

Related items